BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 33188728)

  • 1. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
    Yuan S; Peng L; Park JJ; Hu Y; Devarkar SC; Dong MB; Shen Q; Wu S; Chen S; Lomakin IB; Xiong Y
    Mol Cell; 2020 Dec; 80(6):1055-1066.e6. PubMed ID: 33188728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation.
    Lapointe CP; Grosely R; Johnson AG; Wang J; Fernández IS; Puglisi JD
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33479166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
    Schubert K; Karousis ED; Jomaa A; Scaiola A; Echeverria B; Gurzeler LA; Leibundgut M; Thiel V; Mühlemann O; Ban N
    Nat Struct Mol Biol; 2020 Oct; 27(10):959-966. PubMed ID: 32908316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
    Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
    Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
    Mendez AS; Ly M; González-Sánchez AM; Hartenian E; Ingolia NT; Cate JH; Glaunsinger BA
    Cell Rep; 2021 Oct; 37(3):109841. PubMed ID: 34624207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
    Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
    Shen Z; Zhang G; Yang Y; Li M; Yang S; Peng G
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33151142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Basis of SARS-CoV-2 Nsp1-Induced Immune Translational Shutdown as Revealed by All-Atom Simulations.
    Borišek J; Spinello A; Magistrato A
    J Phys Chem Lett; 2021 Dec; 12(48):11745-11750. PubMed ID: 34851631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
    Vankadari N; Jeyasankar NN; Lopes WJ
    J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
    Banerjee AK; Blanco MR; Bruce EA; Honson DD; Chen LM; Chow A; Bhat P; Ollikainen N; Quinodoz SA; Loney C; Thai J; Miller ZD; Lin AE; Schmidt MM; Stewart DG; Goldfarb D; De Lorenzo G; Rihn SJ; Voorhees RM; Botten JW; Majumdar D; Guttman M
    Cell; 2020 Nov; 183(5):1325-1339.e21. PubMed ID: 33080218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Nsp1 mediated mRNA degradation requires mRNA interaction with the ribosome.
    Shehata SI; Parker R
    RNA Biol; 2023 Jan; 20(1):444-456. PubMed ID: 37415298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.
    Zhang K; Miorin L; Makio T; Dehghan I; Gao S; Xie Y; Zhong H; Esparza M; Kehrer T; Kumar A; Hobman TC; Ptak C; Gao B; Minna JD; Chen Z; García-Sastre A; Ren Y; Wozniak RW; Fontoura BMA
    Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33547084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal features of Nsp1-mediated translational shutdown by coronaviruses.
    Schubert K; Karousis ED; Ban I; Lapointe CP; Leibundgut M; Bäumlin E; Kummerant E; Scaiola A; Schönhut T; Ziegelmüller J; Puglisi JD; Mühlemann O; Ban N
    Mol Cell; 2023 Oct; 83(19):3546-3557.e8. PubMed ID: 37802027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses.
    Devarkar SC; Vetick M; Balaji S; Lomakin IB; Yang L; Jin D; Gilbert WV; Chen S; Xiong Y
    Cell Rep; 2023 Oct; 42(10):113156. PubMed ID: 37733586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation.
    Kumar P; Schexnaydre E; Rafie K; Kurata T; Terenin I; Hauryliuk V; Carlson LA
    FEBS Lett; 2022 May; 596(9):1203-1213. PubMed ID: 35434785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome.
    Tardivat Y; Sosnowski P; Tidu A; Westhof E; Eriani G; Martin F
    Nucleic Acids Res; 2023 Sep; 51(16):8677-8690. PubMed ID: 37503833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage.
    Huang C; Lokugamage KG; Rozovics JM; Narayanan K; Semler BL; Makino S
    PLoS Pathog; 2011 Dec; 7(12):e1002433. PubMed ID: 22174690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation.
    Lokugamage KG; Narayanan K; Huang C; Makino S
    J Virol; 2012 Dec; 86(24):13598-608. PubMed ID: 23035226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA.
    Tanaka T; Kamitani W; DeDiego ML; Enjuanes L; Matsuura Y
    J Virol; 2012 Oct; 86(20):11128-37. PubMed ID: 22855488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
    Finkel Y; Gluck A; Nachshon A; Winkler R; Fisher T; Rozman B; Mizrahi O; Lubelsky Y; Zuckerman B; Slobodin B; Yahalom-Ronen Y; Tamir H; Ulitsky I; Israely T; Paran N; Schwartz M; Stern-Ginossar N
    Nature; 2021 Jun; 594(7862):240-245. PubMed ID: 33979833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.